Acadia Pharma (ACAD) Tops Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $27.68 --0%
Revenue Growth %: +19.1%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +19.1%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.72), $0.01 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $15.29 million versus the consensus estimate of $15.19 million.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- 1-800-FLOWERS.Com (FLWS) Misses Q4 EPS by 10c, Misses on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
